MAPT and tauopathy: Studies on tauopathy patient brain tissue exhibited a correlation between diminished PERK signaling and increased tau pathology, underscoring the protective role of PERK against tau aggregation and suggesting a potential therapeutic target, particularly in individuals with tauopathy-associated PERK hypomorph alleles (Park et al., 2023).